Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.

Cephalalgia · 2021 · PMC8166404 · PMID 33560875

Europe PMC DOI

hedged sentence

0.1390

closest p · 2.8× alpha

0.1390

boldest claim

The sentences

did not reach statistical significancep = 0.139not close (p > 0.1)

In the analysis of ≥ 30% reduction in FPI at week 9, the efficacy of propranolol was greater among migraineurs (adjusted odds ratio [AOR] = 3.3; 95% CL = 1.4, 8.1; p = 0.009; NNT = 3.7) than non-migraineurs (AOR = 1.3; 95% CL = 0.5, 3.2; p = 0.631; NNT = 18.7) although the test for migraine by treatment group interaction did not reach statistical significance ( p = 0.139) ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.